D-Index & Metrics Best Publications

D-Index & Metrics D-index (Discipline H-index) only includes papers and citation values for an examined discipline in contrast to General H-index which accounts for publications across all disciplines.

Discipline name D-index D-index (Discipline H-index) only includes papers and citation values for an examined discipline in contrast to General H-index which accounts for publications across all disciplines. Citations Publications World Ranking National Ranking
Biology and Biochemistry D-index 88 Citations 31,607 306 World Ranking 1702 National Ranking 973

Overview

What is he best known for?

The fields of study he is best known for:

  • Gene
  • DNA
  • Cancer

His primary scientific interests are in Molecular biology, Cancer research, Cell growth, Cell biology and Cell culture. Bruno Calabretta has researched Molecular biology in several fields, including Haematopoiesis and Complementary DNA, MYB, Gene expression, Gene. The Cancer research study combines topics in areas such as Apoptosis, ABL, Chronic myelogenous leukemia, Leukemia and breakpoint cluster region.

His biological study spans a wide range of topics, including Protein biosynthesis, K562 cells, Philadelphia chromosome and Untranslated region. His research integrates issues of Phenotype, Cell cycle and In vitro in his study of Cell growth. His Cell biology research incorporates themes from Cyclin B, Cyclin A and Cyclin D.

His most cited work include:

  • Guidelines for the use and interpretation of assays for monitoring autophagy (3242 citations)
  • Transformation of hematopoietic cells by BCR/ABL requires activation of a PI-3k/Akt-dependent pathway (550 citations)
  • THE BIOLOGY OF CML BLAST CRISIS (485 citations)

What are the main themes of his work throughout his whole career to date?

Molecular biology, Cancer research, Cell biology, Haematopoiesis and Cell culture are his primary areas of study. His Molecular biology research is multidisciplinary, incorporating perspectives in Gene expression, Cellular differentiation, Messenger RNA, Gene and MYB. His Cancer research study combines topics from a wide range of disciplines, such as ABL, Chronic myelogenous leukemia, Leukemia, Stem cell and breakpoint cluster region.

His study in breakpoint cluster region is interdisciplinary in nature, drawing from both Tyrosine kinase and Philadelphia chromosome. The concepts of his Cell biology study are interwoven with issues in Cell cycle, Apoptosis and Transfection. His Cell culture research is multidisciplinary, relying on both Cell growth and Sense.

He most often published in these fields:

  • Molecular biology (45.17%)
  • Cancer research (48.29%)
  • Cell biology (23.36%)

What were the highlights of his more recent work (between 2008-2021)?

  • Cancer research (48.29%)
  • Stem cell (10.90%)
  • Transcription factor (9.97%)

In recent papers he was focusing on the following fields of study:

Bruno Calabretta spends much of his time researching Cancer research, Stem cell, Transcription factor, Cell biology and Leukemia. Bruno Calabretta does research in Cancer research, focusing on Myeloid leukemia specifically. His Stem cell research includes elements of Autophagy, Chronic myelogenous leukemia and Imatinib mesylate.

His Cell biology research incorporates elements of Cell culture and K562 cells. His work in K562 cells addresses issues such as Ccaat-enhancer-binding proteins, which are connected to fields such as Molecular biology and Enhancer binding. His Molecular biology study incorporates themes from Transfection and Phosphorylation.

Between 2008 and 2021, his most popular works were:

  • Guidelines for the use and interpretation of assays for monitoring autophagy (3242 citations)
  • Targeting autophagy potentiates tyrosine kinase inhibitor-induced cell death in Philadelphia chromosome-positive cells, including primary CML stem cells. (459 citations)
  • Inhibiting Interactions of Lysine Demethylase LSD1 with Snail/Slug Blocks Cancer Cell Invasion (90 citations)

In his most recent research, the most cited papers focused on:

  • Gene
  • DNA
  • Cancer

Bruno Calabretta mainly focuses on Cancer research, Stem cell, Myeloid leukemia, Molecular biology and Cancer cell. Bruno Calabretta mostly deals with Imatinib mesylate in his studies of Cancer research. His work carried out in the field of Stem cell brings together such families of science as Autophagy, Chronic myelogenous leukemia, Cellular differentiation and ABL.

His Molecular biology study combines topics in areas such as MYB, Protein stabilization and Cell biology. He works mostly in the field of Cell biology, limiting it down to topics relating to K562 cells and, in certain cases, CD34 and Haematopoiesis. His Cancer cell research focuses on Cancer stem cell and how it relates to breakpoint cluster region.

This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.

Best Publications

Guidelines for the use and interpretation of assays for monitoring autophagy

Daniel J. Klionsky;Fabio C. Abdalla;Hagai Abeliovich;Robert T. Abraham.
Autophagy (2012)

8302 Citations

Transformation of hematopoietic cells by BCR/ABL requires activation of a PI-3k/Akt-dependent pathway

Tomasz Skorski;Alfonso Bellacosa;Margaret Nieborowska‐Skorska;Miroslaw Majewski.
The EMBO Journal (1997)

783 Citations

THE BIOLOGY OF CML BLAST CRISIS

Bruno Calabretta;Danilo Perrotti.
Blood (2004)

662 Citations

Targeting autophagy potentiates tyrosine kinase inhibitor-induced cell death in Philadelphia chromosome-positive cells, including primary CML stem cells.

Cristian Bellodi;Maria Rosa Lidonnici;Ashley Hamilton;G. Vignir Helgason.
Journal of Clinical Investigation (2009)

651 Citations

Multiple signaling pathways of the insulin-like growth factor 1 receptor in protection from apoptosis.

Francesca Peruzzi;Marco Prisco;Michael Dews;Paolo Salomoni.
Molecular and Cellular Biology (1999)

613 Citations

Phosphatidylinositol-3 kinase activity is regulated by BCR/ABL and is required for the growth of Philadelphia chromosome-positive cells

Tomasz Skorski;Palanisamy Kanakaraj;Margaret Nieborowska-Skorska;Mariusz Z. Ratajczak.
Blood (1995)

588 Citations

Inhibition of cellular proliferation by antisense oligodeoxynucleotides to PCNA cyclin

D Jaskulski;Jk deRiel;We Mercer;Bruno Calabretta.
Science (1988)

560 Citations

A c-myb antisense oligodeoxynucleotide inhibits normal human hematopoiesis in vitro

Alan M. Gewirtz;Bruno Calabretta.
Science (1988)

555 Citations

Selective inhibition of leukemia cell proliferation by BCR-ABL antisense oligodeoxynucleotides

Cezary Szczylik;Tomasz Skorski;Nicholas C. Nicolaides;Livia Manzella.
Science (1991)

511 Citations

An oligomer complementary to c-myb-encoded mRNA inhibits proliferation of human myeloid leukemia cell lines.

Giovanni Anfossi;Alan M. Gewirtz;Bruno Calabretta.
Proceedings of the National Academy of Sciences of the United States of America (1989)

408 Citations

If you think any of the details on this page are incorrect, let us know.

Contact us

Best Scientists Citing Bruno Calabretta

Antonio Giordano

Antonio Giordano

Temple University

Publications: 112

Renato V. Iozzo

Renato V. Iozzo

Thomas Jefferson University

Publications: 90

Alan M. Gewirtz

Alan M. Gewirtz

University of Pennsylvania

Publications: 61

Robert G. Ramsay

Robert G. Ramsay

Peter MacCallum Cancer Centre

Publications: 54

Daniel G. Tenen

Daniel G. Tenen

National University of Singapore

Publications: 52

Hagop M. Kantarjian

Hagop M. Kantarjian

The University of Texas MD Anderson Cancer Center

Publications: 47

Renato Baserga

Renato Baserga

Thomas Jefferson University

Publications: 45

Tessa L. Holyoake

Tessa L. Holyoake

University of Glasgow

Publications: 42

Martin E. Gleave

Martin E. Gleave

University of British Columbia

Publications: 40

Jorge E. Cortes

Jorge E. Cortes

Augusta University

Publications: 39

Michael W. Deininger

Michael W. Deininger

Huntsman Cancer Institute

Publications: 34

James D. Griffin

James D. Griffin

Harvard University

Publications: 32

Peter Valent

Peter Valent

Medical University of Vienna

Publications: 28

Ravi Bhatia

Ravi Bhatia

University of Alabama at Birmingham

Publications: 28

Carlo M. Croce

Carlo M. Croce

The Ohio State University

Publications: 28

Mariusz Z. Ratajczak

Mariusz Z. Ratajczak

University of Louisville

Publications: 28

Trending Scientists

Wojciech Maly

Wojciech Maly

Carnegie Mellon University

Rasoul Moradi

Rasoul Moradi

Khazar University

Toshiyuki Mori

Toshiyuki Mori

National Institute for Materials Science

Christopher V. Jahnes

Christopher V. Jahnes

IBM (United States)

Robert Williamson

Robert Williamson

University of Melbourne

Zejun Zhang

Zejun Zhang

China West Normal University

Renée Bergeron

Renée Bergeron

University of Guelph

Kimitsune Ishizaki

Kimitsune Ishizaki

Kobe University

Pontiano Kaleebu

Pontiano Kaleebu

London School of Hygiene & Tropical Medicine

Conrad Childs

Conrad Childs

University College Dublin

Sheila M. Eyberg

Sheila M. Eyberg

University of Florida

José Jalife

José Jalife

Spanish National Centre for Cardiovascular Research

Gary S. Rubin

Gary S. Rubin

University College London

Jan Sundquist

Jan Sundquist

Lund University

Louise Stoll

Louise Stoll

University College London

Jacques Lacan

Jacques Lacan

Université Paris Cité

Something went wrong. Please try again later.